Scatter contamination is a known problem in Computed Tomography (CT) imaging. Previous efforts to employ conventional CT for breast cancer imaging have failed in large part because of the low image quality that results from scatter contamination.

MALCOVA's research, reported in peer-reviewed scientific journals, was the first to demonstrate how significant the problem of scatter contamination is in CT-based breast imaging. This revelation led to our development of an entirely new form of breast imaging technology that is nearly free of scatter contamination, paving the way for a new breast cancer imaging solution the overcomes the limitations of standard-of-care devices in clinical use today.

MALCOVA's patented, CT-based imaging technology uniquely enables high quality, three-dimensional imaging and the detection of tiny traces of cancer at safe levels of patient exposure.